Biofourmis raises $35M to develop smarter treatments for chronic diseases

Biofourmis, a Singapore-based startup pioneering a distinctly tech-based approach to the treatment of chronic conditions, has raised a $35 million Series B round for expansion.

The round was led by Sequoia India and MassMutual Ventures, the VC fund from Massachusetts Mutual Life Insurance Company. Other investors who put in include EDBI, the corporate investment arm of Singapore’s Economic Development Board, China-based healthcare platform Jianke and existing investors Openspace Ventures,...

What feeling does this article give you?

#hashtags to follow:

Singapore [+]    Ventures [+]    EDBI [+]    Economic Development Board [+]    China [+]    Jianke [+]    Openspace Ventures [+]   

More #news: